Coronary artery disease (CAD) is the leading cause of mortality among aortic stenosis (AS) patient populations due to common pathogenetic factors such as ageing, atherosclerotic plaques, multi-morbid risks including diabetes, hypertension and dyslipidaemia, or procedural related coronary access obstruction, with the revolution of transcatheter aortic valve implantation (TAVI). (1) The prevalence of atherosclerotic cardiovascular disease (ASCVD) post TAVI aortic stenotic individuals has become an increasing trend, but its evidence remains debated. (15)
Author Sub-editor: Dr Pok-Tin Tang Dr Pok-Tin Tang is an ST5 cardiology registrar in the Thames Valley deanery, currently undertaking a period of out of
Author Sub-editor: Dr May Hu Dr May Hu is a cardiology trainee in the North West deanery. She graduated with First Class Honours from the University
Author Sub-editor: Dr Jhiamluka Solano Dr Jhiamluka Solano is a cardiology resident doctor (ST6) in the Yorkshire and Humber Deanery, currently undertaking a DPhil (PhD)
Author Sub-editor: Dr Joshua Rowland Dr Joshua Rowland is a cardiology registrar working in the North West Deanery. He graduated from the University of Manchester
Author Sub-editor: Dr Atmadeep Banerjee Dr Atmadeep Banerjee is an ST4 Cardiology Registrar in the Kent, Surrey and Sussex deanery. He graduated from Calcutta National
